Sandoz Eyes First-To-Market US Opportunities With Adalvo Deal

Targeting Six Antifungal/Antibiotic, Oncology And Pulmonary Drugs Worth $3bn

 
• By David Wallace
  
Dice showing all sixes
Sandoz has struck a deal with Adalvo for six products • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business